e-learning
resources
Vienna 2012
Sunday, 02.09.2012
Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The imPAHct of diagnosis delay in pulmonary arterial hypertension
I. Armstrong, C. Harries, J. Yorke (Sheffield, London, United Kingdom)
Source:
Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Session:
Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Session type:
Poster Discussion
Number:
1506
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Armstrong, C. Harries, J. Yorke (Sheffield, London, United Kingdom). The imPAHct of diagnosis delay in pulmonary arterial hypertension. Eur Respir J 2012; 40: Suppl. 56, 1506
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
The diagnosis of pulmonary hypertension
Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease
Year: 2020
Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in children
Source: Eur Respir J 2011; 37: 70-77
Year: 2011
Pulmonary hypertension in children
Source: Eur Respir Mon 2012; 57: 94-107
Year: 2012
Pulmonary arterial hypertension in children
Source: Eur Respir J 2003; 21: 155-176
Year: 2003
Early detection and management of pulmonary arterial hypertension
Source: Eur Respir Rev 2012 21: 306-312
Year: 2012
Pulmonary function in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010
The future of treatment for pulmonary arterial hypertension
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Year: 2018
The future of treatment for pulmonary arterial hypertension
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014
The future of treatment for pulmonary arterial hypertension
Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease
Year: 2012
The future of treatment for pulmonary arterial hypertension
Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2017
The influence of fractional pulse pressure on the outcome of pulmonary thromboendarterectomy
Source: Eur Respir J 2001; 17: 653-659
Year: 2001
When is pulmonary hypertension not pulmonary hypertension?
Source: Eur Respir J 2001; 18: Suppl. 33, 522s
Year: 2001
Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension
Source: Eur Respir J 2009; 34: 770
Year: 2009
Single arterial occlusion to locate resistance in patients with pulmonary hypertension
Source: Eur Respir J 2003; 21: 31-36
Year: 2003
Diagnosis of pulmonary arterial hypertension in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 335s
Year: 2005
Pulmonary hypertension: pathophysiology and diagnosis
Source: Annual Congress 2007 - PG19 - Pulmonary vascular disorders: diagnosis and treatment
Year: 2007
COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey
Source: ERJ Open Res, 6 (4) 00520-2020; 10.1183/23120541.00520-2020
Year: 2020
Prognosis in pulmonary arterial hypertension
Source: Eur Respir J 2011; 37: 971-972
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept